Bonnie L. Bassler, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 4,446 shares at $686.99 ($3.1M) on 2022-09-08, disclosed to the SEC on 2022-09-12.
Open-market sale of $3.1M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $686.99 | 1,279 | $879K | 28.3% |
| 2 | $686.99 | 1,279 | $879K | 28.3% |
| 3 | $705.00 | 1,279 | $902K | 29.0% |
| 4 | $741.00 | 609 | $451K | 14.5% |
| Total | $699.57 avg | 4,446 | $3.1M | 100% |
| Filing → |
| REGN | SELL | 2024-08-19 | $885K | — | Filing → |
| REGN | SELL | 2024-08-05 | $843K | — | Filing → |
| REGN | SELL | 2024-06-25 | $803K | — | Filing → |